参 考 文 献

Phase Ⅱ trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer .Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small- ......